145162-36-3

Basic information

• Product Name: 1H-Pyrrole-2-carboxylicacid,3-amino-4-cyano-1-methyl-,ethylester(9CI)
• Synonyms: 1H-Pyrrole-2-carboxylicacid,3-amino-4-cyano-1-methyl-,ethylester(9CI);3-Amino-4-cyano-1-methyl-1H-pyrrole-2-carboxylic acid ethyl ester
• CAS NO: 145162-36-3
• Molecular Formula: C₉H₁₁N₃O₂
• Molecular Weight: 193.21
• Product Categories: AMINOACID;CARBOXYLICESTER
• Mol File: 145162-36-3.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1H-Pyrrole-2-carboxylicacid,3-amino-4-cyano-1-methyl-,ethylester(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrrole-2-carboxylicacid,3-amino-4-cyano-1-methyl-,ethylester(9CI)(145162-36-3)
• EPA Substance Registry System: 1H-Pyrrole-2-carboxylicacid,3-amino-4-cyano-1-methyl-,ethylester(9CI)(145162-36-3)

Safety Data

• Hazardous Substances Data: 145162-36-3(Hazardous Substances Data)

Usage

Structure

1H-Pyrrole-2-carboxylic acid derivative with an ethyl ester group, an amino group, and a cyano group

Type

Chemical compound

Applications

Potential use in the pharmaceutical industry for drug development, as well as in research and development of organic synthesis

Further investigation needed

The exact properties and potential uses of this compound require additional research and study.

Upstream product

• 52605-49-9 sarcosine ethyl ester hydrochloride 
• 123-06-8 Ethoxymethylenemalononitrile 
• 79080-32-3 2-((methylamino)methylene)malononitrile 
• 105-36-2 ethyl bromoacetate 

Downstream Products

• 731824-28-5 5-methyl-4-(4-phenethylpiperazin-1-yl)-5H-pyrrolo[3,2-d]-pyrimidine-7-carbonitrile 

Relevant articles and documents

INDAZOLES AND AZAINDAZOLES AS LRRK2 INHIBITORS

The present invention is directed to indazole and azaindazole compounds which are inhibitors of LRRK2 and are useful in the treatment of CNS disorders.

Pyrrolopyrimidine derivatives and purine analogs as novel activators of Multidrug Resistance-associated Protein 1 (MRP1, ABCC1)

Multidrug resistance (MDR) is the main cause of diminished success in cancer chemotherapy. ABC transport proteins are considered to be one important factor of MDR. Besides P-glycoprotein (P-gp, ABCB1) and Breast Cancer Resistance Protein (BCRP, ABCG2), Mu

PYRROLE AND PYRAZOLE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS

The present invention relates to pyrrole and pyrazole compounds of formula (I) and their pharmaceutically acceptable salts, and further relates to their use in treating schizophrenia, cognitive deficits associated with schizophrenia, Alzheimer's disease, dementia of the Alzheimer's type, mild cognitive impairment, or depression. The compounds act as potentiators on glutamate receptors, in particular AMPA and the GluR family.